全文获取类型
收费全文 | 5231篇 |
免费 | 531篇 |
国内免费 | 288篇 |
专业分类
电工技术 | 427篇 |
综合类 | 484篇 |
化学工业 | 469篇 |
金属工艺 | 323篇 |
机械仪表 | 284篇 |
建筑科学 | 283篇 |
矿业工程 | 243篇 |
能源动力 | 175篇 |
轻工业 | 453篇 |
水利工程 | 155篇 |
石油天然气 | 136篇 |
武器工业 | 103篇 |
无线电 | 484篇 |
一般工业技术 | 383篇 |
冶金工业 | 1011篇 |
原子能技术 | 65篇 |
自动化技术 | 572篇 |
出版年
2024年 | 38篇 |
2023年 | 97篇 |
2022年 | 196篇 |
2021年 | 279篇 |
2020年 | 169篇 |
2019年 | 110篇 |
2018年 | 140篇 |
2017年 | 153篇 |
2016年 | 121篇 |
2015年 | 178篇 |
2014年 | 229篇 |
2013年 | 303篇 |
2012年 | 356篇 |
2011年 | 408篇 |
2010年 | 356篇 |
2009年 | 357篇 |
2008年 | 331篇 |
2007年 | 324篇 |
2006年 | 291篇 |
2005年 | 204篇 |
2004年 | 165篇 |
2003年 | 96篇 |
2002年 | 97篇 |
2001年 | 67篇 |
2000年 | 57篇 |
1999年 | 40篇 |
1998年 | 241篇 |
1997年 | 134篇 |
1996年 | 91篇 |
1995年 | 56篇 |
1994年 | 47篇 |
1993年 | 54篇 |
1992年 | 14篇 |
1991年 | 11篇 |
1990年 | 13篇 |
1989年 | 13篇 |
1988年 | 16篇 |
1987年 | 11篇 |
1986年 | 16篇 |
1985年 | 12篇 |
1983年 | 3篇 |
1982年 | 9篇 |
1981年 | 13篇 |
1980年 | 12篇 |
1978年 | 4篇 |
1977年 | 31篇 |
1976年 | 68篇 |
1975年 | 6篇 |
1972年 | 2篇 |
1955年 | 3篇 |
排序方式: 共有6050条查询结果,搜索用时 15 毫秒
1.
有机-无机压电材料是一种分子铁电体,具有柔性、结构灵活、易成膜、全液相合成及环保节能等优点,可满足新一代薄膜器件及可穿戴设备的需求。该文以三甲基卤代甲基铵(TMXM, X=F, Cl, Br)为有机部分,MnCl2为无机部分,通过溶液蒸发法制备了具有钙钛矿分子结构的有机-无机压电材料三甲基氯三氯化锰(TMCM-MnCl3),并对其分子结构组成、压电、热学、声学及铁电性进行表征。结果表明,TMCM-MnCl3的压电常数为106 pC/N,居里温度为130 ℃,声阻抗值约为16.5 MRayl,低于压电陶瓷PZT-4(大于33 MRayl),具有广阔的应用前景。 相似文献
2.
高性能纺织品整理方法及其应用 总被引:1,自引:0,他引:1
1 加工方法1 1 涂层纺织品的涂层可在多种设备上完成 ,其中最常用的是使用刮刀、辊筒、凹辊、粘辊和背辊。用于生产给定的最终产品时 ,每一种设备都有其优缺点 ,所以在选择时 ,我们应该对以下几点进行认真考虑 :纺织品的性质 ;涂层剂的流变性及其他性质 ;涂层剂是泡沫型的还是浆料型的 ;涂层剂在常温下还是在热熔条件下使用。另外 ,非常值得我们考虑的还有涂层剂的用量 ,以及涂层剂是用在织物的表面 ,还是尽量充满到织物结构内。所有这些都要由最终产品的性质及所要求具有的特种功能来确定。当前 ,除了涂层剂及织物的普通性能外 ,人们还… 相似文献
3.
4.
Bill Woodruff 《电子设计技术》2005,12(1):136-136,138-139
较低的速度通常不能算是创新,但在10 Gbps以太网的领域内,两种“低速”互连标准,即LX4和CX4,正在降低实现成本,并实现新的应用。 相似文献
5.
Insulin receptor substrate (IRS) proteins are key regulators of basic functions such as cellular growth and metabolism. They provide an interface between multiple receptors and a complex network of intracellular signaling molecules. Two members of this family (IRS-1 and IRS-2) have been identified previously. In this investigation, we analyzed a mouse expressed sequence tag clone that proved to be a new member of the IRS family. Sequence analysis of this clone and comparison with the sequences deposited in GenBank demonstrates this protein may be the murine homolog of rat IRS-3, recently purified and cloned from rat adipocytes. Accordingly, we have named our protein mouse IRS-3. The expressed sequence tag clone contains the complete coding sequence of 1485 bp, encoding a protein of 495 amino acids. Sequence alignment with the other members of the IRS family shows that this protein contains pleckstrin homology and phosphotyrosine-binding domains that are highly conserved. In addition, there is conservation of many tyrosine phosphorylation motifs responsible for interactions with downstream signaling molecules containing SH2 domains. The murine IRS-3 messenger RNA (2.4 kilobases in length) is expressed in many tissues, with highest levels in liver and lung. Mouse IRS-3 is highly expressed in the first part of the embryonic life, when IRS-1 messenger RNA is barely detectable. Unlike the genes encoding IRS-1 and IRS-2, the IRS-3 gene contains an intron (344 bp in length) in the region between the pleckstrin homology and the phosphotyrosine-binding domains. Fluorescent in situ hybridization localized the mouse IRS-3 gene on the telomeric region of chromosome 5G2. Cloning of the murine IRS-3 gene will make it possible to apply genetic approaches to elucidate the physiological role of this new member of the IRS family of proteins. 相似文献
6.
双乙醛草酰二肼直接快速光度法测定食品中痕量铜 总被引:1,自引:0,他引:1
研究了双乙醛草酸二肼与铜的显色反应,建立了分光光度法直接测定铜的新方法。试验结果表明,在pH8.0-10.0范围内,Cu2 与双乙醛草酸二肼形成稳定的紫红色配合物。该配合物在540nm处有一最大吸收峰,其表明摩尔吸光系数为2.4×104,铜量在0-12mg/50ml范围内符合比尔定律。共存离子干扰,误差仅 2.00%。用于食品中痕量钢测定.结果准确、可靠。 相似文献
7.
8.
当线路末端故障时,行波在线路末端的反射情况比较复杂,反向电流行波的极性有可能与正向电流行波的极性相反,而此时测距结果又与线路无故障时相同。因此,会造成行波测距式与行波极性比较式合闸保护的不正确动作。根据行波的折、反射理论,分析出当线路无故障时正向电流行波仅在线路末端发生反射,且电流行波的反射系数为-1,而当线路存在故障时,正向电流行波将在故障点发生反射,无论故障是否在线路末端,电流行波的反射系数都不会是-1。根据这一特征,提出了一种新的行波合闸保护方法。从原理上保证了在各种情况下保护都可以正确动作,大量的电磁暂态仿真结果也证明了这一点。 相似文献
9.
10.
EJ Shpall SM Stemmer L Hami WA Franklin L Shaw HS Bonner SI Bearman WP Peters RC Bast W McCulloch 《Canadian Metallurgical Quarterly》1994,83(11):3132-3137
4-Hydroperoxycyclophosphamide (4-HC), a commonly used marrow-purging agent, is active against many tumors, but is also toxic to normal marrow progenitors. Amifostine (WR-2721) is a sulfhydryl compound with chemoprotectant activity. Preclinical studies using suspensions of bone marrow and breast cancer cells demonstrated that ex vivo treatment with amifostine followed by 4-HC resulted in protection of marrow progenitors, with no compromise in the antitumor effect of 4-HC. This fact stimulated the development of a clinical trial. Bone marrow was harvested from 15 poor-prognosis breast cancer patients and randomly assigned to ex vivo treatment with amifostine followed by 4-HC (amifostine + 4-HC), or treatment with 4-HC alone. High-dose chemotherapy was then administered followed by infusion of the purged autologous bone marrow support (ABMS). Leukocyte engraftment, defined as a white blood cell count > or = 1 x 10(9)/L, was achieved in an average of 26 days for patients whose marrow was purged with amifostine + 4-HC versus 36 days for patients whose marrow was purged with 4-HC alone (P = .032). The average number of platelet transfusions (12 v 29; P = .017) and days of antibiotic therapy (28 v 40; P = .012) were significantly less for patients whose marrow was exposed to amifostine + 4-HC, compared with 4-HC alone. Unpurged backup marrow fractions were infused into three patients whose marrow was purged with 4-HC alone, because of inadequate marrow recovery. None of the patients who received amifostine + 4-HC-purged marrow required a backup marrow fraction. Complete remissions were achieved in 83% of patients with measurable disease, with no difference between the two cohorts. Forty-three percent of patients remained alive and progression-free at a mean of 13 months posttransplant. There was no significant difference in the rate or pattern of relapse for patients whose marrow was purged with amifostine + 4-HC compared with those whose marrow was purged with 4-HC alone. Ex vivo treatment of marrow with amifostine significantly shortens the time to marrow recovery, thereby reducing the risk of myelosuppressive complications in breast cancer patients receiving high-dose chemotherapy and 4-HC-purged ABMS. Since supportive care requirements are also significantly decreased, amifostine may reduce the cost of such therapy. 相似文献